The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence of MET and HER2 biomarkers in stage IV gastric cancer.
Robert D. Loberg
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Rui Tang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Kelly Smith Oliner
Employment or Leadership Position - Amgen (I); Amgen
Stock Ownership - Amgen (I); Amgen